Literature DB >> 27330453

2014 Epilepsy Benchmarks Area IV: Limit or Prevent Adverse Consequence of Seizures and Their Treatment Across The Lifespan.

Alica M Goldman1, W Curt LaFrance2, Tim Benke3, Miya Asato4, Dan Drane5, Alison Pack6, Tanvir Syed7, Robert Doss8, Samden Lhatoo9, Brandy Fureman10, Ray Dingledine11.   

Abstract

Entities:  

Year:  2016        PMID： 27330453      PMCID： PMC4913859          DOI： 10.5698/1535-7511-16.3.198

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  75 in total

1.  Health-related quality of life and emotional well-being in parents of children with epilepsy referred for presurgical evaluation in Sweden.

Authors:  Colin Reilly; Charles Taft; Maria Nelander; Kristina Malmgren; Ingrid Olsson
Journal:  Epilepsy Behav       Date:  2015-10-24       Impact factor: 2.937

Review 2.  Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach: a report from the International League Against Epilepsy Nonepileptic Seizures Task Force.

Authors:  W Curt LaFrance; Gus A Baker; Rod Duncan; Laura H Goldstein; Markus Reuber
Journal:  Epilepsia       Date:  2013-09-20       Impact factor: 5.864

Review 3.  Neuronal migration disorders: Focus on the cytoskeleton and epilepsy.

Authors:  Melissa A Stouffer; Jeffrey A Golden; Fiona Francis
Journal:  Neurobiol Dis       Date:  2015-08-20       Impact factor: 5.996

Review 4.  The neurology of mTOR.

Authors:  Jonathan O Lipton; Mustafa Sahin
Journal:  Neuron       Date:  2014-10-22       Impact factor: 17.173

5.  Automated differentiation between epileptic and nonepileptic convulsive seizures.

Authors:  Sándor Beniczky; Isa Conradsen; Mihai Moldovan; Poul Jennum; Martin Fabricius; Krisztina Benedek; Noémi Andersen; Helle Hjalgrim; Peter Wolf
Journal:  Ann Neurol       Date:  2015-01-17       Impact factor: 10.422

Review 6.  Migraine pathophysiology: lessons from mouse models and human genetics.

Authors:  Michel D Ferrari; Roselin R Klever; Gisela M Terwindt; Cenk Ayata; Arn M J M van den Maagdenberg
Journal:  Lancet Neurol       Date:  2015-01       Impact factor: 44.182

7.  Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.

Authors:  Kimford J Meador; Gus A Baker; Nancy Browning; Morris J Cohen; Rebecca L Bromley; Jill Clayton-Smith; Laura A Kalayjian; Andres Kanner; Joyce D Liporace; Page B Pennell; Michael Privitera; David W Loring
Journal:  Lancet Neurol       Date:  2013-01-23       Impact factor: 44.182

8.  Psychiatric comorbidity in epilepsy: a population-based analysis.

Authors:  Jose F Tellez-Zenteno; Scott B Patten; Nathalie Jetté; Jeanne Williams; Samuel Wiebe
Journal:  Epilepsia       Date:  2007-07-28       Impact factor: 5.864

9.  Childhood absence epilepsy: behavioral, cognitive, and linguistic comorbidities.

Authors:  Rochelle Caplan; Prabha Siddarth; Lesley Stahl; Erin Lanphier; Pamela Vona; Suresh Gurbani; Susan Koh; Raman Sankar; W Donald Shields
Journal:  Epilepsia       Date:  2008-06-13       Impact factor: 5.864

10.  Emotional dysregulation, alexithymia, and attachment in psychogenic nonepileptic seizures.

Authors:  Richard J Brown; Julia F Bouska; Anna Frow; Antonia Kirkby; Gus A Baker; Steven Kemp; Christine Burness; Markus Reuber
Journal:  Epilepsy Behav       Date:  2013-08-22       Impact factor: 2.937
View more
  6 in total

1.  Spectrum and time course of epilepsy and the associated cognitive decline in MECP2 duplication syndrome.

Authors:  Dana Marafi; Bernhard Suter; Rebecca Schultz; Daniel Glaze; Valory N Pavlik; Alica M Goldman
Journal:  Neurology       Date:  2018-12-14       Impact factor: 9.910

Review 2.  Recent Advances in Neuroimaging of Epilepsy.

Authors:  Adam M Goodman; Jerzy P Szaflarski
Journal:  Neurotherapeutics       Date:  2021-05-03       Impact factor: 7.620

3.  Antiepileptogenesis and disease modification: Progress, challenges, and the path forward-Report of the Preclinical Working Group of the 2018 NINDS-sponsored antiepileptogenesis and disease modification workshop.

Authors:  Aristea S Galanopoulou; Wolfgang Löscher; Laura Lubbers; Terence J O'Brien; Kevin Staley; Annamaria Vezzani; Raimondo D'Ambrosio; H Steve White; Harald Sontheimer; John A Wolf; Roy Twyman; Vicky Whittemore; Karen S Wilcox; Brian Klein
Journal:  Epilepsia Open       Date:  2021-05-06

4.  The 2021 Epilepsy Research Benchmarks-Respecting Core Principles, Reflecting Evolving Community Priorities.

Authors:  Eric D Marsh; Vicky Whittemore; Miriam Leenders; Annapurna Poduri
Journal:  Epilepsy Curr       Date:  2021-06-30       Impact factor: 7.500

5.  Epilepsy Benchmarks Area IV: Limit or Prevent Adverse Consequence of Seizures and Their Treatment Across the Life Span.

Authors:  Jana E Jones; Miya R Asato; Mesha-Gay Brown; Julia L Doss; Elizabeth A Felton; Jennifer A Kearney; Delia Talos; Penny A Dacks; Vicky Whittemore; Annapurna Poduri
Journal:  Epilepsy Curr       Date:  2020-01-23       Impact factor: 7.500

6.  The Benchmarks: Progress and Emerging Priorities in Epilepsy Research.

Authors:  Annapurna Poduri; Vicky Holets Whittemore
Journal:  Epilepsy Curr       Date:  2019-12-23       Impact factor: 7.500
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.